Singapore Medical Group
CATALIST-LISTED healthcare play Singapore Medical Group (SMG) on Wednesday announced that it is deepening its partnership with CHA Healthcare Singapore, as the latter increases its stake in SMG from...
CHA Healthcare Singapore has entered into a share purchase agreement to invest S$50 million in Catalist-listed Singapore Medical Group (SMG), increasing its stake from 6.86 per cent to 24.13 per cent...
SINGAPORE Medical Group on Tuesday posted a net profit of S$2.94 million for the fourth quarter ended Dec 31, up 17.2 per cent from a year ago.
SINGAPORE Medical Group's earnings surged in the third quarter, tracking a rise in revenue and helped by the group's share of results where joint ventures and associates had earlier...
SINGAPORE Medical Group (SMG) may implement a formal dividend policy in fiscal 2019 along with a share buy-back mandate as part of its plan to enhance shareholder value, the Catalist-listed clinic...
SINGAPORE Medical Group (SMG), a specialist practitioner focused on women's health and wellness, on Tuesday reported a net profit of S$3.42 million for its first quarter ended March 31, 2018,...
CATALIST-listed clinic operator Singapore Medical Group (SMG) said on Friday night that a suit had been brought against it on Oct 30 last year, relating to alleged trademark and copyright...
DBS Equity Research has issued a 'Buy' recommendation on Singapore Medical Group (SMG) with a target price of S$0.73 a share. ...

Breakfast Brief every morning |
Daily Debrief every evening |
